Fresenius Medical Care AG is the world's leading provider of products and services for people with renal (kidney) disease. As of December 31, 2025 it cared for more than 292,000 patients across roughly 3,600 dialysis centers and operated around 35 production sites worldwide, covering the entire dialysis value chain from machines and dialyzers to disposables, pharmaceuticals and clinical care delivery. Formed in 1996 by merging Fresenius AG's dialysis division with W.R. Grace's National Medical Care, it is headquartered in Bad Homburg, Germany and listed on the Frankfurt Stock Exchange (DAX, FME) and NYSE via ADRs (FMS).